BetterLife Pharma (BETRF) EBITDA (2015 - 2022)
BetterLife Pharma (BETRF) posted quarterly EBITDA of -$2.4 million for Q2 2022, down 24.87% year-over-year from -$3.1 million in Q2 2021, and up 21.23% quarter-over-quarter from -$3.0 million in Q1 2022.
BetterLife Pharma (BETRF) EBITDA (2015 - 2022) Analysis & Trends
BetterLife Pharma's EBITDA history runs 8 years deep, the most recent figure standing at -$2.4 million for Q2 2022.
- In Q2 2022, EBITDA fell 24.87% year-over-year to -$2.4 million; the TTM figure through Apr 2022 stood at -$10.0 million (up 66.49% YoY), while the FY2026 annual figure was -$1.2 million, up 67.11% from the prior year.
- EBITDA for Q2 2022 stood at -$2.4 million, up from -$3.0 million in the prior quarter.
- The five-year high for EBITDA was -$9030.5 in Q2 2020, with the low at -$21.2 million in Q1 2021.
- The 5-year median for EBITDA is -$1.6 million (2018), against an average of -$3.3 million.
- The sharpest annual moves came in 2020 and 2021: EBITDA soared 99.28% in 2020, then sank 20789.18% in 2021.
- BetterLife Pharma's EBITDA stood at -$1.4 million in 2018, then rose by 11.6% to -$1.2 million in 2019, then sank by 352.42% to -$5.6 million in 2020, then surged by 68.89% to -$1.8 million in 2021, then sank by 34.11% to -$2.4 million in 2022.
- Business Quant data shows BETRF's EBITDA at -$2.4 million in Q2 2022, -$3.0 million in Q1 2022, and -$1.8 million in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.29 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 493.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -815.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 325.05 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 231.44 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -1.55 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 133.12 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -375.75 Mn |
| 10 | BetterLife Pharma | 40.15 Mn | 42.53 Mn | - | -426,847.83 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2022 | -2.36 Mn |
| Jan 31, 2022 | -2.99 Mn |
| Oct 31, 2021 | -1.76 Mn |
| Jul 31, 2021 | -2.92 Mn |
| Apr 30, 2021 | -1.89 Mn |
| Jan 31, 2021 | -21.22 Mn |
| Oct 31, 2020 | -5.65 Mn |
| Jul 31, 2020 | -1.15 Mn |
| Apr 30, 2020 | -9,030.52 |
| Apr 30, 2019 | -1.25 Mn |
| Oct 31, 2018 | -1.41 Mn |
| Jul 31, 2018 | -1.18 Mn |
| Apr 30, 2018 | -1.45 Mn |
| Jan 31, 2018 | -330,324.00 |
| Jul 31, 2017 | -248,755.00 |
| Apr 30, 2017 | -285,518.00 |
| Jan 31, 2017 | -822,138.00 |
| Oct 31, 2016 | -690,304.00 |
| Jul 31, 2016 | -1.18 Mn |
| Apr 30, 2016 | -3.33 Mn |